These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18971629)

  • 1. TorsinA protein degradation and autophagy in DYT1 dystonia.
    Giles LM; Li L; Chin LS
    Autophagy; 2009 Jan; 5(1):82-4. PubMed ID: 18971629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystonia-associated mutations cause premature degradation of torsinA protein and cell-type-specific mislocalization to the nuclear envelope.
    Giles LM; Chen J; Li L; Chin LS
    Hum Mol Genet; 2008 Sep; 17(17):2712-22. PubMed ID: 18552369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells.
    Hewett JW; Tannous B; Niland BP; Nery FC; Zeng J; Li Y; Breakefield XO
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7271-6. PubMed ID: 17428918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.
    Gonzalez-Alegre P; Paulson HL
    J Neurosci; 2004 Mar; 24(11):2593-601. PubMed ID: 15028751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of Protein Processing in the Endoplasmic Reticulum of DYT1 Knock-in Mice Implicates Novel Pathways in Dystonia Pathogenesis.
    Beauvais G; Bode NM; Watson JL; Wen H; Glenn KA; Kawano H; Harata NC; Ehrlich ME; Gonzalez-Alegre P
    J Neurosci; 2016 Oct; 36(40):10245-10256. PubMed ID: 27707963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of the DYT1 mutation on torsinA oligomerization and degradation.
    Gordon KL; Gonzalez-Alegre P
    Neuroscience; 2008 Dec; 157(3):588-95. PubMed ID: 18940237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Printor, a novel torsinA-interacting protein implicated in dystonia pathogenesis.
    Giles LM; Li L; Chin LS
    J Biol Chem; 2009 Aug; 284(32):21765-75. PubMed ID: 19535332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA knock-down of mutant torsinA restores processing through secretory pathway in DYT1 dystonia cells.
    Hewett JW; Nery FC; Niland B; Ge P; Tan P; Hadwiger P; Tannous BA; Sah DW; Breakefield XO
    Hum Mol Genet; 2008 May; 17(10):1436-45. PubMed ID: 18258738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TorsinA participates in endoplasmic reticulum-associated degradation.
    Nery FC; Armata IA; Farley JE; Cho JA; Yaqub U; Chen P; da Hora CC; Wang Q; Tagaya M; Klein C; Tannous B; Caldwell KA; Caldwell GA; Lencer WI; Ye Y; Breakefield XO
    Nat Commun; 2011 Jul; 2():393. PubMed ID: 21750546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of torsinA in dystonia.
    Granata A; Warner TT
    Eur J Neurol; 2010 Jul; 17 Suppl 1():81-7. PubMed ID: 20590813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TorsinA and dystonia: from nuclear envelope to synapse.
    Granata A; Schiavo G; Warner TT
    J Neurochem; 2009 Jun; 109(6):1596-609. PubMed ID: 19457118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.
    Hettich J; Ryan SD; de Souza ON; Saraiva Macedo Timmers LF; Tsai S; Atai NA; da Hora CC; Zhang X; Kothary R; Snapp E; Ericsson M; Grundmann K; Breakefield XO; Nery FC
    Hum Mutat; 2014 Sep; 35(9):1101-13. PubMed ID: 24930953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BiP molecular chaperone plays multiple roles during the biogenesis of torsinA, an AAA+ ATPase associated with the neurological disease early-onset torsion dystonia.
    Zacchi LF; Wu HC; Bell SL; Millen L; Paton AW; Paton JC; Thomas PJ; Zolkiewski M; Brodsky JL
    J Biol Chem; 2014 May; 289(18):12727-47. PubMed ID: 24627482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response.
    Chen P; Burdette AJ; Porter JC; Ricketts JC; Fox SA; Nery FC; Hewett JW; Berkowitz LA; Breakefield XO; Caldwell KA; Caldwell GA
    Hum Mol Genet; 2010 Sep; 19(18):3502-15. PubMed ID: 20584926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin ligase F-box/G-domain protein 1 promotes the degradation of the disease-linked protein torsinA through the ubiquitin-proteasome pathway and macroautophagy.
    Gordon KL; Glenn KA; Bode N; Wen HM; Paulson HL; Gonzalez-Alegre P
    Neuroscience; 2012 Nov; 224():160-71. PubMed ID: 22917612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein.
    Goodchild RE; Dauer WT
    J Cell Biol; 2005 Mar; 168(6):855-62. PubMed ID: 15767459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia.
    Gonzalez-Alegre P; Bode N; Davidson BL; Paulson HL
    J Neurosci; 2005 Nov; 25(45):10502-9. PubMed ID: 16280588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TorsinA and DYT1 dystonia: a synaptopathy?
    Warner TT; Granata A; Schiavo G
    Biochem Soc Trans; 2010 Apr; 38(2):452-6. PubMed ID: 20298201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nuclear envelope localization of DYT1 dystonia torsinA-ΔE requires the SUN1 LINC complex component.
    Jungwirth MT; Kumar D; Jeong DY; Goodchild RE
    BMC Cell Biol; 2011 May; 12():24. PubMed ID: 21627841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling cellular phenotypes of novel TorsinA/TOR1A mutations.
    Vulinovic F; Lohmann K; Rakovic A; Capetian P; Alvarez-Fischer D; Schmidt A; Weißbach A; Erogullari A; Kaiser FJ; Wiegers K; Ferbert A; Rolfs A; Klein C; Seibler P
    Hum Mutat; 2014 Sep; 35(9):1114-22. PubMed ID: 24931141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.